| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.095 | 0.6 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.082 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |